{"id":116,"date":"2023-04-13T12:00:43","date_gmt":"2023-04-13T12:00:43","guid":{"rendered":"https:\/\/d36deud6t4mnhi.cloudfront.net\/?page_id=116"},"modified":"2024-12-03T08:07:23","modified_gmt":"2024-12-03T06:07:23","slug":"press-release","status":"publish","type":"page","link":"https:\/\/www.ipsen.com\/press-release\/","title":{"rendered":"Press Releases"},"content":{"rendered":"    <section class=\"sub-page-banner bg-img\" style=\"background-image:url(https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/10\/07095609\/A-b_MEDIA-PR_202407_1920x720pix.jpg)\">\n        <div class=\"container content-sec\" role=\"main\" id=\"main\">\n            <nav aria-label=\"breadcrumb\">\n            <ol class=\"breadcrumb\">\n                <li class=\"breadcrumb-item\"><a href=\"https:\/\/www.ipsen.com\">Home<\/a><\/li><li class=\"breadcrumb-item active\" aria-current=\"page\">Press Releases<\/li><\/ol>\n            <\/nav>            <h1 class=\"visible\">Press Releases<\/h1>\n            <p class=\"visible\">A comprehensive library of Ipsen media releases for investors and members of the press. <\/p>\n        <\/div>\n    <\/section>\n\n\n\n<section class=\"media-tabs\">\n      <div class=\"container\">\n        <div class=\"media-tabs-inner\">\n          <ul class=\"media-list-ul\">\n                              <li class=\"media-list-items\">\n                      <a class=\"media-item-link active\" href=\"https:\/\/www.ipsen.com\/press-release\/\" tabindex=\"0\">Press Releases<\/a>\n                  <\/li>\n                              <li class=\"media-list-items\">\n                      <a class=\"media-item-link \" href=\"https:\/\/www.ipsen.com\/media-statements\/\" tabindex=\"0\">Media Statements<\/a>\n                  <\/li>\n                              <li class=\"media-list-items\">\n                      <a class=\"media-item-link \" href=\"https:\/\/www.ipsen.com\/media-library\/\" tabindex=\"0\">Media Library<\/a>\n                  <\/li>\n                      <\/ul>\n          <div id=\"navTabArrows\">\n              <div class=\"tab-nav-arrows\" id=\"tab-nav-prev\"><\/div>\n              <div class=\"tab-nav-arrows\" id=\"tab-nav-next\"><\/div>\n          <\/div>\n        <\/div>\n      <\/div>\n<\/section>\n\n    <section class=\"slim-card  none\">\n        <div class=\"container\">\n          <div class=\"slim-card-inner\">\n                         <div class=\"slim-standard-section\">\n    <div class=\"slim-standard-section-inner\">\n        <div class=\"row reverse-div\">\n            \n            <div class=\"column-12 col-xl-12 col-md-12 col-sm-12\">\n                <!-- slim-standard carousel -->\n                <div class=\"slim-standard-carousel multiple\">\n                    <div class=\"glider-contain\">\n                                                    <div class=\"slim-standard-content-btn\">\n                                <button aria-label=\"Previous\" class=\"glider-slim-standard-prev disabled\" aria-disabled=\"true\">\n                                    <span><\/span>\n                                <\/button>\n                                <button aria-label=\"Next\" class=\"glider-slim-standard-next\" aria-disabled=\"false\">\n                                    <span><\/span>\n                                <\/button>\n                            <\/div>\n                        \n                        <div class=\"glider-slim-standard\">\n                                                            <div class=\"slim-standard-tab glider-slide left-0\" data-gslide=\"0 active visible\" tab-index=\"0\">\n                                    <div class=\"highligth-row\">\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-biomunex-announce-exclusive-global-licensing-agreement-for-first-in-class-mait-cell-engager-in-immuno-oncology-2990251\/\"  aria-label=\"Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-biomunex-announce-exclusive-global-licensing-agreement-for-first-in-class-mait-cell-engager-in-immuno-oncology-2990251\/\" >\n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/28120505\/PR_final.jpeg\" aria-label=\"Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology\" title=\"Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology\" >\n                                                            <\/a>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-biomunex-announce-exclusive-global-licensing-agreement-for-first-in-class-mait-cell-engager-in-immuno-oncology-2990251\/\"  aria-label=\"Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button class=\"btn small-btn grey-bg visible\" style=\"background-color:#4e6e9a;\"> Partnering <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 03 December 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n\n                                        <\/div>\n                                <\/div>\n                                                        <div class=\"slim-standard-tab glider-slide left-1\" data-gslide=\"1  \" tab-index=\"0\">\n                                    <div class=\"highligth-row\">\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/bylvay-odevixibat-data-shows-sustained-improvement-in-severe-itch-and-serum-bile-acid-levels-in-patients-with-pfic-and-algs-2982434\/\"  aria-label=\"Bylvay\u00ae (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <a href=\"https:\/\/www.ipsen.com\/press-releases\/bylvay-odevixibat-data-shows-sustained-improvement-in-severe-itch-and-serum-bile-acid-levels-in-patients-with-pfic-and-algs-2982434\/\" >\n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/28120505\/PR_final.jpeg\" aria-label=\"Bylvay\u00ae (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in...\" title=\"Bylvay\u00ae (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in...\" >\n                                                            <\/a>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/bylvay-odevixibat-data-shows-sustained-improvement-in-severe-itch-and-serum-bile-acid-levels-in-patients-with-pfic-and-algs-2982434\/\"  aria-label=\"Bylvay\u00ae (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button class=\"btn small-btn grey-bg visible\" style=\"background-color:#7dc1e5;\"> Rare Diseases <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 18 November 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Bylvay\u00ae (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n\n                                        <\/div>\n                                <\/div>\n                                                        <div class=\"slim-standard-tab glider-slide left-2\" data-gslide=\"2  \" tab-index=\"0\">\n                                    <div class=\"highligth-row\">\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/iqirvo-elafibranor-data-shows-efficacy-and-safety-for-up-to-3-years-in-patients-with-pbc-with-improvements-in-fatigue-and-pruritus-2982128\/\"  aria-label=\"Iqirvo\u00ae (elafibranor) data shows efficacy and safety for up to 3 years in patients with...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <a href=\"https:\/\/www.ipsen.com\/press-releases\/iqirvo-elafibranor-data-shows-efficacy-and-safety-for-up-to-3-years-in-patients-with-pbc-with-improvements-in-fatigue-and-pruritus-2982128\/\" >\n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/28120505\/PR_final.jpeg\" aria-label=\"Iqirvo\u00ae (elafibranor) data shows efficacy and safety for up to 3 years in patients with...\" title=\"Iqirvo\u00ae (elafibranor) data shows efficacy and safety for up to 3 years in patients with...\" >\n                                                            <\/a>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/iqirvo-elafibranor-data-shows-efficacy-and-safety-for-up-to-3-years-in-patients-with-pbc-with-improvements-in-fatigue-and-pruritus-2982128\/\"  aria-label=\"Iqirvo\u00ae (elafibranor) data shows efficacy and safety for up to 3 years in patients with...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button class=\"btn small-btn grey-bg visible\" style=\"background-color:#7dc1e5;\"> Rare Diseases <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 15 November 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Iqirvo\u00ae (elafibranor) data shows efficacy and safety for up to 3 years in patients with&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n\n                                        <\/div>\n                                <\/div>\n                                                        <div class=\"slim-standard-tab glider-slide left-3\" data-gslide=\"3  \" tab-index=\"0\">\n                                    <div class=\"highligth-row\">\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-delivers-strong-sales-momentum-in-the-first-nine-months-of-2024-and-increases-its-full-year-guidance-2967449\/\"  aria-label=\"Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-delivers-strong-sales-momentum-in-the-first-nine-months-of-2024-and-increases-its-full-year-guidance-2967449\/\" >\n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/28120505\/PR_final.jpeg\" aria-label=\"Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its...\" title=\"Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its...\" >\n                                                            <\/a>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-delivers-strong-sales-momentum-in-the-first-nine-months-of-2024-and-increases-its-full-year-guidance-2967449\/\"  aria-label=\"Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button class=\"btn small-btn grey-bg visible\" style=\"background-color:#06768e;\"> Financial <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 23 October 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n\n                                        <\/div>\n                                <\/div>\n                                                        <div class=\"slim-standard-tab glider-slide left-4\" data-gslide=\"4  \" tab-index=\"0\">\n                                    <div class=\"highligth-row\">\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsens-kayfanda-odevixibat-approved-in-european-union-for-cholestatic-pruritus-in-alagille-syndrome-a-rare-liver-disease-2951259\/\"  aria-label=\"Ipsen\u2019s Kayfanda\u00ae (odevixibat) approved in European Union for cholestatic pruritus in Alagille Syndrome, a rare...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsens-kayfanda-odevixibat-approved-in-european-union-for-cholestatic-pruritus-in-alagille-syndrome-a-rare-liver-disease-2951259\/\" >\n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/09\/17091122\/PR_final.jpeg\" aria-label=\"Ipsen\u2019s Kayfanda\u00ae (odevixibat) approved in European Union for cholestatic pruritus in Alagille Syndrome, a rare...\" title=\"Ipsen\u2019s Kayfanda\u00ae (odevixibat) approved in European Union for cholestatic pruritus in Alagille Syndrome, a rare...\" >\n                                                            <\/a>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsens-kayfanda-odevixibat-approved-in-european-union-for-cholestatic-pruritus-in-alagille-syndrome-a-rare-liver-disease-2951259\/\"  aria-label=\"Ipsen\u2019s Kayfanda\u00ae (odevixibat) approved in European Union for cholestatic pruritus in Alagille Syndrome, a rare...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button class=\"btn small-btn grey-bg visible\" style=\"background-color:#7dc1e5;\"> Rare Diseases <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 23 September 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Ipsen\u2019s Kayfanda\u00ae (odevixibat) approved in European Union for cholestatic pruritus in Alagille Syndrome, a rare&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n\n                                        <\/div>\n                                <\/div>\n                                                        <div class=\"slim-standard-tab glider-slide left-5\" data-gslide=\"5  \" tab-index=\"0\">\n                                    <div class=\"highligth-row\">\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsens-iqirvo-elafibranor-approved-in-the-european-union-as-first-new-treatment-for-primary-biliary-cholangitis-in-nearly-a-decade-2949674\/\"  aria-label=\"Ipsen\u2019s Iqirvo\u00ae (elafibranor) approved in the European Union as first new treatment for primary biliary...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsens-iqirvo-elafibranor-approved-in-the-european-union-as-first-new-treatment-for-primary-biliary-cholangitis-in-nearly-a-decade-2949674\/\" >\n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/09\/17091122\/PR_final.jpeg\" aria-label=\"Ipsen\u2019s Iqirvo\u00ae (elafibranor) approved in the European Union as first new treatment for primary biliary...\" title=\"Ipsen\u2019s Iqirvo\u00ae (elafibranor) approved in the European Union as first new treatment for primary biliary...\" >\n                                                            <\/a>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsens-iqirvo-elafibranor-approved-in-the-european-union-as-first-new-treatment-for-primary-biliary-cholangitis-in-nearly-a-decade-2949674\/\"  aria-label=\"Ipsen\u2019s Iqirvo\u00ae (elafibranor) approved in the European Union as first new treatment for primary biliary...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button class=\"btn small-btn grey-bg visible\" style=\"background-color:#7dc1e5;\"> Rare Diseases <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 20 September 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Ipsen\u2019s Iqirvo\u00ae (elafibranor) approved in the European Union as first new treatment for primary biliary&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n\n                                        <\/div>\n                                <\/div>\n                                                        <div class=\"slim-standard-tab glider-slide left-6\" data-gslide=\"6  \" tab-index=\"0\">\n                                    <div class=\"highligth-row\">\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsens-iqirvo-receives-u-s-fda-accelerated-approval-as-a-first-in-class-ppar-treatment-for-primary-biliary-cholangitis\/\"  aria-label=\"Ipsen\u2019s Iqirvo\u00ae receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary...\">\n                                            <div class=\"column-1\">\n                                                <div class=\"slim-standard-img\">\n                                                                                                                <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsens-iqirvo-receives-u-s-fda-accelerated-approval-as-a-first-in-class-ppar-treatment-for-primary-biliary-cholangitis\/\" >\n                                                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/28120505\/PR_final.jpeg\" aria-label=\"Ipsen\u2019s Iqirvo\u00ae receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary...\" title=\"Ipsen\u2019s Iqirvo\u00ae receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary...\" >\n                                                            <\/a>\n                                                        \n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n                                        <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsens-iqirvo-receives-u-s-fda-accelerated-approval-as-a-first-in-class-ppar-treatment-for-primary-biliary-cholangitis\/\"  aria-label=\"Ipsen\u2019s Iqirvo\u00ae receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary...\">\n                                            <div class=\"column-2\">\n                                                <div class=\"slim-standard-content\">\n                                                    <div class=\"slim-standard-tab-sec\">\n                                                        <button class=\"btn small-btn grey-bg visible\" style=\"background-color:#7dc1e5;\"> Rare Diseases <\/button>\n                                                        <p class=\"date-time dark-grey visible\">  &#8211; 10 June 2024 <\/p>\n                                                    <\/div>\n                                                    <div class=\"slim-standard-para-sec\">\n                                                        <p class=\"slim-standard-para primary-blue\">\n                                                            Ipsen\u2019s Iqirvo\u00ae receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary&#8230;                                                        <\/p>\n                                                    <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/a>\n\n                                        <\/div>\n                                <\/div>\n                                                <\/div>\n                    <\/div>\n\n                <\/div><!--standard-carousel-over -->\n            <\/div><!--grid-div-over -->\n        <\/div>\n\n        <div class=\"slimcard-btn-sec\">\n                    <\/div>\n\n    <\/div>\n<\/div>\n           <\/div>\n        <\/div>\n    <\/section>\n\n\n\n<div class=\"wp-block-columns alignfull is-layout-flex wp-container-core-columns-is-layout-1 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:75%\">\n<section class=\"media-filter\">\n    <div class=\"container media-filter-inner\">\n                <h2 class=\"media-filter-title charcoal-grey\">Explore more press releases<\/h2>\n                <div class=\"media-filter-main\" id=\"search-total-div\" data-langaugecode=\"en\" data-paginationtype=\"visible\" data-loadmore=\"hidden\" data-filtertype=\"pressrelease\" data-posttype=\"press_release\"\n            data-pagination=\"visible\" data-parenttermid=\"[1763,1764,1765,1766,1767,1769,1770,1772,1773]\">\n            <div class=\"row\">\n                <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                                        <!-- media drop down -->\n                    <div class=\"media-drop-down\">\n                        <p class=\"media-drop-heading\">Filter<\/p>\n                        <div class=\"media-dropdown-items\">\n                            <div class=\"row\">\n                                                            <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                                    <div class=\"topic-filter\">\n                                                                                <p>Topics<\/p>\n                                                                                <div class=\"mutltiselect-dropdown topic-cat-dropdown\">\n                                            <select name=\"langOpt[]\" multiple id=\"topicOpt\">\n                                                                                                <option value=\"1763\">Corporate                                                <\/option>\n                                                                                                <option value=\"1764\">Financial                                                <\/option>\n                                                                                                <option value=\"1765\">Neuroscience                                                <\/option>\n                                                                                                <option value=\"1766\">News                                                <\/option>\n                                                                                                <option value=\"1767\">Oncology                                                <\/option>\n                                                                                                <option value=\"1769\">Partnering                                                <\/option>\n                                                                                                <option value=\"1770\">Rare Diseases                                                <\/option>\n                                                                                                <option value=\"1772\">Research                                                <\/option>\n                                                                                                <option value=\"1773\">Sustainability                                                <\/option>\n                                                                                            <\/select>\n                                        <\/div>\n                                    <\/div>\n                                <\/div>\n                                                                                                                                <div class=\"column-2 col-lg-4 col-md-4 col-sm-12\">\n                                    <div class=\"period-filter\">\n                                            <p>Period<\/p>\n                                          <div class=\"mutltiselect-dropdown year-dropdown\">\n                                            <select name=\"langOpt[]\" multiple id=\"periodOpt\">\n                                                                                            <option value=\"2024\">2024                                                                                            <option value=\"2023\">2023                                                                                            <option value=\"2022\">2022                                                                                            <option value=\"2021\">2021                                                                                            <option value=\"2020\">2020                                                                                            <option value=\"2019\">2019                                                                                            <option value=\"2018\">2018                                                                                            <option value=\"2017\">2017                                                                                            <option value=\"2016\">2016                                                                                            <option value=\"2015\">2015                                                                                        <\/select>\n                                        <\/div>\n                                    <\/div>\n                                <\/div>\n                                \n                                                                                                            <div class=\"column-3 col-lg-4 col-md-4 \">\n                                            <div class=\"filterby-filter\">\n                                                <p>Filter by<\/p>\n                                                <div class=\"input-filter\">\n                                                    <input type=\"search\" name=\"filter-by\" id=\"filter-by\"\n                                                        placeholder=\"Type a keyword\">\n                                                <\/div>\n                                                <div class=\"filter-by-dropdown\">\n                                                    <p class=\"recent\">recent search<\/p>\n                                                                                                        <ul class=\"filter-by-list\">\n                                                                                                            <\/ul>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                                                                                                              <\/div>\n                            <div class=\"reset-btn-div\">\n                                <a href=\"#\" class=\"reset-btn\">Reset<\/a>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n                                        <!-- sorting section -->\n                    \t\t\t\t\t\t\n        <section class=\"media-filter\">\n            <div class=\"container media-filter-inner\">\n                <div class=\"media-filter-main\" id=\"search-total-div\" data-langaugecode=\"en\" data-paginationtype=\"visible\" data-loadmore=\"hidden\" data-filtertype=\"investor-event\" data-posttype=\"event\" data-pagination=\"visible\" data-parenttermid=\"[492,493,1810,494]\">\n                    <div class=\"row\">\n                        <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                        <div class=\"sorting-sec\">\n                            <div class=\"row\">\n                                                                    <div class=\"column-1 col-xl-6 col-lg-6 col-sm-12\">\n                                        <div class=\"no-of-item-sec\">\n                                            <p>Showing: <span id=\"start-value\">1<\/span> &#8211; <span id=\"no-of-search\">05<\/span> of <span id=\"total-count\">207<\/span>\n                                                <\/p>\n                                        <\/div>\n                                    <\/div>\n                                                                <div class=\"column-2 col-xl-6 col-lg-6 col-sm-12\">\n                                                                            <div class=\"sort-input\">\n                                            <div class=\"sort-input-inner\">\n                                            <label for=\"sorting-input\">Show<\/label>\n                                                                                            <select name=\"order\" aria-label=\"5\" id=\"show-list\">\n                                                    <option value=\"05\" selected>05<\/option>\n                                                    <option value=\"10\" >10<\/option>\n                                                    <option value=\"20\" >20<\/option>\n                                                    <option value=\"30\" >30<\/option>\n                                                    <option value=\"40\" >40<\/option>\n                                                    <option value=\"50\" >50<\/option>\n                                                <\/select>\n                                            <\/div>\n                                        <\/div>\n\t\t\t\t\t\t\t\t\n                                                                                                                <div class=\"sort-input-ascending\">\n                                            <div class=\"sort-input-ascending-inner\">\n                                                <label for=\"sorting-input-ascend\">Sort<\/label>\n                                                <select name=\"sorting-input-ascend\" id=\"show-list-as\" aria-label=\"Ascending\">\n                                                    <option value=\"ASC\"  >Ascending<\/option>\n                                                    <option value=\"DESC\" selected>Descending<\/option>\n                                                <\/select>\n                                            <\/div>\n                                        <\/div>                                        \n                                                                    <\/div>\n                            <\/div>\n                        <\/div>\n                        <\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\n\t\t<\/section>\n                                       \n                    <!-- Search listing include start here-->\n                    <div id=\"search-results\" class=\"story-div\">\n                        <!-- Press Release Listing start here -->\n<div class=\"story-div\" id=\"search-div\">\n\t<div>\n<div class=\"row story-row pr-card\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-biomunex-announce-exclusive-global-licensing-agreement-for-first-in-class-mait-cell-engager-in-immuno-oncology-2990251\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/28120505\/PR_final.jpeg\" alt=\"Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology\" title=\"Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology\"\/><\/a>\n                                    <\/div>\n            <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#4e6e9a\">\n                        Partnering                    <\/button>\n                    <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/radio.png\"\n                        class=\"radio-img desk-span\" alt=\"Press Release Icon\" title=\"Press Release Icon\" width=\"auto\">\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">03 December 2024                            <!-- <span class=\"story-read-time\">6 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">03 December 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                <div class=\"download\">\n                    <a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/609f6702-b380-431b-81a3-339136043b1f\" download>\n                        <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/download.png\" alt=\"Download\" title=\"Download\"\/>\n                    <\/a>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-and-biomunex-announce-exclusive-global-licensing-agreement-for-first-in-class-mait-cell-engager-in-immuno-oncology-2990251\/\">\n                        <h5 class=\"blue-txt\">Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology<\/h5>\n                    <\/a>\n                    <p class=\"second-post-para\">PARIS, FRANCE; 03 December 2024 &#8211; Ipsen (Euronext: IPN; ADR: IPSEY) and Biomunex Pharmaceuticals today announced an exclusive global licensing agreement for BMX-502. BMX-502 is a bispecific antibody that engages and activates a subset of cytotoxic T cells called Mucosal-Associated&#8230;<\/p>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div>\n<div class=\"row story-row pr-card\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/www.ipsen.com\/press-releases\/bylvay-odevixibat-data-shows-sustained-improvement-in-severe-itch-and-serum-bile-acid-levels-in-patients-with-pfic-and-algs-2982434\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/28120505\/PR_final.jpeg\" alt=\"Bylvay\u00ae (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS\" title=\"Bylvay\u00ae (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS\"\/><\/a>\n                                    <\/div>\n            <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#7dc1e5\">\n                        Rare Diseases                    <\/button>\n                    <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/radio.png\"\n                        class=\"radio-img desk-span\" alt=\"Press Release Icon\" title=\"Press Release Icon\" width=\"auto\">\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">18 November 2024                            <!-- <span class=\"story-read-time\">12 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">18 November 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                <div class=\"download\">\n                    <a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/355fddf1-a1ef-4c57-b449-a09729386b32\" download>\n                        <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/download.png\" alt=\"Download\" title=\"Download\"\/>\n                    <\/a>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/press-releases\/bylvay-odevixibat-data-shows-sustained-improvement-in-severe-itch-and-serum-bile-acid-levels-in-patients-with-pfic-and-algs-2982434\/\">\n                        <h5 class=\"blue-txt\">Bylvay\u00ae (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS<\/h5>\n                    <\/a>\n                    <p class=\"second-post-para\">PARIS, FRANCE, 18 November, 2024 Ipsen (Euronext: IPN; ADR: IPSEY) today announced data at the American Association for the Study of Liver Diseases (AASLD) assessing the long-term efficacy and safety of patients treated with Bylvay\u00ae from two Phase III open-label&#8230;<\/p>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div>\n<div class=\"row story-row pr-card\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/www.ipsen.com\/press-releases\/iqirvo-elafibranor-data-shows-efficacy-and-safety-for-up-to-3-years-in-patients-with-pbc-with-improvements-in-fatigue-and-pruritus-2982128\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/28120505\/PR_final.jpeg\" alt=\"Iqirvo\u00ae (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus\" title=\"Iqirvo\u00ae (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus\"\/><\/a>\n                                    <\/div>\n            <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#7dc1e5\">\n                        Rare Diseases                    <\/button>\n                    <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/radio.png\"\n                        class=\"radio-img desk-span\" alt=\"Press Release Icon\" title=\"Press Release Icon\" width=\"auto\">\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">15 November 2024                            <!-- <span class=\"story-read-time\">12 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">15 November 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                <div class=\"download\">\n                    <a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/aff95761-691f-40e8-a64d-c1713222bf44\" download>\n                        <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/download.png\" alt=\"Download\" title=\"Download\"\/>\n                    <\/a>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/press-releases\/iqirvo-elafibranor-data-shows-efficacy-and-safety-for-up-to-3-years-in-patients-with-pbc-with-improvements-in-fatigue-and-pruritus-2982128\/\">\n                        <h5 class=\"blue-txt\">Iqirvo\u00ae (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus<\/h5>\n                    <\/a>\n                    <p class=\"second-post-para\">PARIS, FRANCE, 15 November 2024 Ipsen (Euronext: IPN; ADR: IPSEY) announced today late-breaking data for Iqirvo\u00ae (elafibranor 80 mg tablets) from an interim analysis of the ongoing open-label extension of the Phase III ELATIVE\u00ae study at the American Association for&#8230;<\/p>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div>\n<div class=\"row story-row pr-card\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-delivers-strong-sales-momentum-in-the-first-nine-months-of-2024-and-increases-its-full-year-guidance-2967449\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/28120505\/PR_final.jpeg\" alt=\"Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full-year guidance\" title=\"Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full-year guidance\"\/><\/a>\n                                    <\/div>\n            <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#06768e\">\n                        Financial                    <\/button>\n                    <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/radio.png\"\n                        class=\"radio-img desk-span\" alt=\"Press Release Icon\" title=\"Press Release Icon\" width=\"auto\">\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">23 October 2024                            <!-- <span class=\"story-read-time\">4 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">23 October 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                <div class=\"download\">\n                    <a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/e6af395e-776b-4847-a45f-f0672e93c54b\" download>\n                        <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/download.png\" alt=\"Download\" title=\"Download\"\/>\n                    <\/a>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-delivers-strong-sales-momentum-in-the-first-nine-months-of-2024-and-increases-its-full-year-guidance-2967449\/\">\n                        <h5 class=\"blue-txt\">Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full-year guidance<\/h5>\n                    <\/a>\n                    <p class=\"second-post-para\">PARIS, FRANCE, 23 October 2024 &#8211; Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its performance for the year to date and the third quarter of 2024.<\/p>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n<section class=\"card-accordion\">\n    <div class=\"accordion filter-card-accord\">\n        <div class=\"accordion-item shadow-none\">\n            <h2 class=\"accordion-header\" id=\"headingOne\">\n                <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\"\n                    data-bs-target=\"#collapseOne-69785\" aria-expanded=\"false\" aria-controls=\"collapseOne\">\n                    <span class=\"link-icon\">\n                        <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/download-link.png\" alt=\"Download\"  title=\"Download\"\/>\n                    <\/span> 4 related documents\/links<\/button>\n            <\/h2>\n            <div id=\"collapseOne-69785\" class=\"accordion-collapse collapse\" aria-labelledby=\"headingOne\"\n                data-bs-parent=\"#accordionExample\">\n                <div class=\"accordion-body\">\n                                        <p>\n                        <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/10\/23065626\/Ipsen-YTD-2024-sales-announcement.pdf\"\n                            target=\"_blank\">YTD 2024 &#8211; results announcement<span class=\"link-res-icon\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/pdf.png\" alt=\"Download\"  title=\"Download\"\/>\n                            <\/span>\n                            <span class=\"file-size-info\">\n                                (583.38 KB)\n                            <\/span>\n                        <\/a>\n                    <\/p>\n                    <hr>                     <p>\n                        <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/10\/23065624\/Ipsen-YTD-2024-highlights.pdf\"\n                            target=\"_blank\">YTD 2024 &#8211; highlights<span class=\"link-res-icon\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/pdf.png\" alt=\"Download\"  title=\"Download\"\/>\n                            <\/span>\n                            <span class=\"file-size-info\">\n                                (334.23 KB)\n                            <\/span>\n                        <\/a>\n                    <\/p>\n                    <hr>                     <p>\n                        <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/10\/24164500\/Ipsen-YTD-2024-sales-presentation-1.pdf\"\n                            target=\"_blank\">YTD 2024 &#8211; sales presentation<span class=\"link-res-icon\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/pdf.png\" alt=\"Download\"  title=\"Download\"\/>\n                            <\/span>\n                            <span class=\"file-size-info\">\n                                (1.25 MB)\n                            <\/span>\n                        <\/a>\n                    <\/p>\n                    <hr>                                      <p>\n                                         <a href=\"http:\/\/ipsen.to\/YTD-2024-sales-update\" target=\"_blank\">\n                                             Webcast replay                                                                                                  <span class=\"link-res-icon\">\n                                                         <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/hyperlink.png\" alt=\"Link\" title=\"Link\"\/>\n                                                     <\/span>\n                                                                                      <\/a>\n                                     <\/p>\n                                          <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\t\t\n<\/div>\n<br>\n\t\t\t<div>\n<div class=\"row story-row pr-card\">\n    <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                        <div class=\"story-img\">\n                                            <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-receives-its-second-shingo-prize-for-operational-excellence-2962739\/\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/28120505\/PR_final.jpeg\" alt=\"Ipsen receives its second Shingo Prize for operational excellence\" title=\"Ipsen receives its second Shingo Prize for operational excellence\"\/><\/a>\n                                    <\/div>\n            <\/div>\n    <div class=\"column-2 col-lg-8 col-md-8 col-sm-12\">\n        <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                    <button class=\"btn tag-btn\" style=\"background-color:#4e6e9a\">\n                        Corporate                    <\/button>\n                    <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/radio.png\"\n                        class=\"radio-img desk-span\" alt=\"Press Release Icon\" title=\"Press Release Icon\" width=\"auto\">\n                    <span class=\"desk-span\">&nbsp;&#8211;&nbsp;\n                        <span class=\"story-date\">14 October 2024                            <!-- <span class=\"story-read-time\">5 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">14 October 2024<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                <div class=\"download\">\n                    <a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/6abe6c83-c23e-4d3c-8323-520ec88f827d\" download>\n                        <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/download.png\" alt=\"Download\" title=\"Download\"\/>\n                    <\/a>\n                <\/div>\n                                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-receives-its-second-shingo-prize-for-operational-excellence-2962739\/\">\n                        <h5 class=\"blue-txt\">Ipsen receives its second Shingo Prize for operational excellence<\/h5>\n                    <\/a>\n                    <p class=\"second-post-para\">PARIS, FRANCE, 14 October 2024 &#8211; Ipsen (Euronext: IPN; ADR: IPSEY) announced today that its Dublin, Ireland production site has received the Shingo Prize for operational excellence. This is Ipsen\u2019s second Shingo Prize, with its site in Signes, France, receiving&#8230;<\/p>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div class=\"pagination\"><span class='page-numbers current'>1<\/span><a class='page-numbers' onclick='paginationClick(2)'>2<\/a><span class='page-numbers dots'>&#8230;<\/span><a class='page-numbers' onclick='paginationClick(42)'>42<\/a><a class='next page-numbers' onclick='paginationClick(2)'><\/a><\/div><\/div>\n<!-- Press Release Listing Ends here -->\n                        <!-- Search listing include end here-->\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:25%\">\n    <section class=\"side-panel contacts-card\">\n        <div class=\"container\">\n            <div class=\"side-media-contacts\">\n    <div class=\"media-contacts-head visible\">\n        <p>Your dedicated contacts<\/p>\n    <\/div>\n    <div class=\"media-contacts-list\">\n        <div class=\"main-media-contact-list\">\n                               <ul>\n                        <li>\n                            <p class=\"name-label visible\">Media Relations<\/p>\n                            <p class=\"designation-label\"><\/p>\n                            <p class=\"designation-country visible\"><\/p>\n                        <\/li>\n                        <li class=\"parent-list\">\n                          <ul> \n                            \n                                                            <li>\n                                    <ul class=\"phone-child visible\" >\n                                        <li class=\"phone\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/phone.png\" alt=\"Phone Number\" title=\"Phone Number\"><\/li>\n                                        <li class=\"phone-number\"><a href=\"tel:+33 1 58 33 50 00\" id=\"user_phone\">+33 1 58 33 50 00<\/a><\/li>\n                                        <li class=\"copy-icon\"><img decoding=\"async\" class=\"desktop-view\" data-value=\"+33 1 58 33 50 00\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/copied.png\" alt=\"Copy Phone Number\" title=\"Copy Phone Number\" ><\/li>\n                                    <\/ul>\n                                <\/li>\n                            \n                              \n\n                                                            <li>\n                                    <ul class=\"email-child visible\">\n                                        <li class=\"email\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/email.png\" alt=\"Email Address\" title=\"Email Address\"><\/li>\n                                        <li class=\"email-id\"><a href=\"mailto:IpsenMediaRelations@ipsen.com\" id=\"user_email\">IpsenMediaRelations@ipsen.com<\/a><\/li>\n                                        <li class=\"copy-icon\"><img decoding=\"async\" class=\"desktop-view\" data-value=\"IpsenMediaRelations@ipsen.com\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/copied.png\" alt=\"Copy Email Address\" title=\"Copy Email Address\"><\/li>\n                                    <\/ul>\n                                <\/li>\n                            \n                                                      <\/ul>          \n                        <\/li>\n                                                    <li class=\"mobile-view\">\n                                <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/08\/30172637\/Media-Relations.vcf\" class=\"mobile-only add-to-contacts\">\n                                    <img decoding=\"async\" class=\"mobile-only add-contacts\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/add-to-contacts.png\" title=\"Add to contacts\" alt=\"Add to contacts\" >\n                                <\/a>\n                            <\/li>\n                                            <\/ul>\n\n                    <hr class=\"down-divider hidden\"> \n                                 \n        <\/div>\n\n        \n    <\/div>\n<\/div>        <\/div> \n    <\/section>\n\n\n    <section class=\"side-panel quick-links\">\n        <div class=\"container\">\n            <div class=\"quick-link-inner\">\n                <div class=\"quick-link-head visible\">\n                    <p class=\"quicklink-block-title\">Stay updated<\/p>\n                <\/div>\n                <div class=\"quick-link-list\">\n                    <ul style=\"border: 1px solid #C4C9CB\">\n                                                        <li>\n                                   <a href=\"https:\/\/www.ipsen.com\/news-registration-iframe\/\" target=\"\">\n                                        Register to receive our latest news                                    <\/a>\n                                <\/li>\n                                                <\/ul>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/section>\n<\/div>\n<\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-116","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen Press Releases | Latest News &amp; Updates<\/title>\n<meta name=\"description\" content=\"Stay updated with the latest news and updates from Ipsen. Read our press releases for insights into our recent research, partnerships, and breakthroughs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/press-release\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen Press Releases | Latest News &amp; Updates\" \/>\n<meta property=\"og:description\" content=\"Stay updated with the latest news and updates from Ipsen. Read our press releases for insights into our recent research, partnerships, and breakthroughs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/press-release\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-03T06:07:23+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/press-release\/\",\"url\":\"https:\/\/www.ipsen.com\/press-release\/\",\"name\":\"Ipsen Press Releases | Latest News & Updates\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/#website\"},\"datePublished\":\"2023-04-13T12:00:43+00:00\",\"dateModified\":\"2024-12-03T06:07:23+00:00\",\"description\":\"Stay updated with the latest news and updates from Ipsen. Read our press releases for insights into our recent research, partnerships, and breakthroughs.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/press-release\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/press-release\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/press-release\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press Releases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/#website\",\"url\":\"https:\/\/www.ipsen.com\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen Press Releases | Latest News & Updates","description":"Stay updated with the latest news and updates from Ipsen. Read our press releases for insights into our recent research, partnerships, and breakthroughs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/press-release\/","og_locale":"en_US","og_type":"article","og_title":"Ipsen Press Releases | Latest News & Updates","og_description":"Stay updated with the latest news and updates from Ipsen. Read our press releases for insights into our recent research, partnerships, and breakthroughs.","og_url":"https:\/\/www.ipsen.com\/press-release\/","og_site_name":"Global","article_modified_time":"2024-12-03T06:07:23+00:00","twitter_card":"summary_large_image","twitter_site":"@ipsengroup","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/press-release\/","url":"https:\/\/www.ipsen.com\/press-release\/","name":"Ipsen Press Releases | Latest News & Updates","isPartOf":{"@id":"https:\/\/www.ipsen.com\/#website"},"datePublished":"2023-04-13T12:00:43+00:00","dateModified":"2024-12-03T06:07:23+00:00","description":"Stay updated with the latest news and updates from Ipsen. Read our press releases for insights into our recent research, partnerships, and breakthroughs.","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/press-release\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/press-release\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/press-release\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/"},{"@type":"ListItem","position":2,"name":"Press Releases"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/#website","url":"https:\/\/www.ipsen.com\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages\/116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/comments?post=116"}],"version-history":[{"count":93,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages\/116\/revisions"}],"predecessor-version":[{"id":72223,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages\/116\/revisions\/72223"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/media?parent=116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}